Skip to main content
Premium Trial:

Request an Annual Quote

Epic Sciences Metastatic Breast Cancer Circulating Tumor Cell Panel

Epic Sciences has released a new single-cell profiling panel for metastatic breast cancer, which alllows analysis of a wide variety of targets, including tumor cell burden, clinically relevant hormone receptor status, and genomic drivers. The panel also enables evaluation of individual CTCs for phenotypic heterogenaity and for novel morphologic signatures that can indicate things like homologous recombination deficiency.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.